Clarient’s Board of Directors Recommends Stockholders Accept General Electric’s Cash Tender Offer
Clarient’s Board of Directors Recommends Stockholders Accept General Electric’s Cash Tender Offer
ALISO VIEJO, Calif., Nov. 5, 2010 /PRNewswire-FirstCall/ — Clarient, Inc. (Nasdaq: CLRT) announced today that its board of directors has unanimously agreed to recommend that Clarient stockholders tender their shares to General Electric Company (NYSE: GE) at the previously announced price of $5.00 per share of Clarient’s common stock and $20.00 per share of Clarient’s Series A Convertible …
Read more on redOrbit
Categories: Breast Cancer Information Tags: accept, board, Cash, Clarient's, Directors, Electric's, General, offer, recommends, Stockholders, Tender
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and the prevention of infectious disease, announced today that it has appointed Dr Kapil Dhingra to the Board of Directors as a Non-Executive.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Tumor Tags: Appoints, BioVex, board, Dhingra, Directors, Head, Kapil, Oncology, Roche
ZIOPHARM Elects George B. Abercrombie, former CEO of Hoffmann-La Roche, to Board of Directors
ZIOPHARM Elects George B. Abercrombie, former CEO of Hoffmann-La Roche, to Board of Directors
NEW YORK—-ZIOPHARM Oncology, Inc. , announced today the appointment of George B. Abercrombie to its Board of Directors. Mr. Abercrombie will serve as a member of the Board’s Compensation Committee as well as the Nominating and Corporate Governance Committee.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Research Tags: Abercrombie, board, Directors, Elects, Former, George, HoffmannLa, Roche, ZIOPHARM